LRRK2 and Parkinson disease: Although there is no overt neurodegeneration in SNpc of LRRK2 KI mice, perturbations in nigro-striatal neurotransmission pathways observed in KI models may reflect early synaptic dysfunction leading to PD in humans, suggesting potential therapeutic benefits of targeting pre- and post-synaptic functions prior to the disease onset.